August 29, 2025

Gastrointestinal Foreign Bodies: When to Use Computed Tomography Versus Radiograph

A physician-focused review of gastrointestinal foreign body ingestion is looking to guide triage and intervention.

Conexiant

August 28, 2025

CD68/CD163 Mark Worse Outcomes in Skeletal Hodgkin Lymphoma, Study

Skeletal classic Hodgkin lymphoma shows a macrophage-rich, B-cell–poor microenvironment, with high CD68/CD163 linked to worse survival.

Conexiant

August 28, 2025

Can Gene Therapy Outperform Implants?

Children receiving gene therapy showed superior hearing and speech perception metrics.

Conexiant

August 27, 2025

Educational, Digital, Campaign Tools Cut Antibiotic Use

Antibiotic prescribing for common respiratory tract infections was more frequent in urgent care than in primary care, with patterns shaped by patient age and diagnosis.

Conexiant

August 27, 2025

Fetal Brain Risks Tied to Common Analgesic

Using the Navigation Guide framework, researchers synthesized heterogeneous evidence on prenatal acetaminophen exposure, noting variability in study design, outcome measures, and potential confounding.

Conexiant

August 27, 2025

Emerging PD-1 Inhibitor Plus Chemotherapy Shows Efficacy in Second-Line Classical Hodgkin Lymphoma

The addition of the PD-1 inhibitor sintilimab to ICE (ifosfamide, carboplatin, and etoposide) chemotherapy appeared to significantly improve the complete remission rate and showed a trend toward impro...

The ASCO Post

August 27, 2025

Medical Oddities: Is Smoking Good for the Gut?

From ulcerative colitis’ smoky paradox to protein power, boba belly, hair-friendly diets, and sibling rivalries.

Conexiant

August 26, 2025

Are Daily Drinks Causing Hair Loss?

Comprehensive analysis reveals specific dietary interventions that significantly impact hair health, with some beverages showing harmful effects.

Conexiant

August 25, 2025

Baricitinib Aids Eyebrow, Eyelash Regrowth in Alopecia Areata

This study highlights baricitinib’s effectiveness in promoting eyebrow and eyelash regrowth in patients with alopecia areata across two phase III clinical trials.

Conexiant